sv8
 

As filed with the Securities and Exchange Commission on August 4, 2006                                                    
Registration No. 333 -               
 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM S-8
REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933

 
DYNAVAX TECHNOLOGIES CORPORATION
(Exact Name of Registrant as Specified in its Charter)
 
     
Delaware
(State of Incorporation)
  33-0728374
(I.R.S. Employer Identification Number)
2929 Seventh Street, Suite 100
Berkeley, CA 94710
(510) 848-5100

(Address, Including Zip Code, and Telephone Number,
Including Area Code, of Registrant’s Principal Executive Offices)
 
2004 Stock Incentive Plan
2004 Employee Stock Purchase Plan

(Full Title of the Plan)
 
Deborah A. Smeltzer
Vice President, Operations and Chief Financial Officer
Dynavax Technologies Corporation
2929 Seventh Street, Suite 100
Berkeley, CA 94710
(510) 848-5100

(Name, Address, Including Zip Code, and Telephone Number,
Including Area Code, of Agent for Service)
 
Copies to:
Robert L. Jones, Esq.
Glen Y. Sato, Esq.
Cooley Godward LLP
Five Palo Alto Square
3000 El Camino Real
Palo Alto, CA 94306

 
CALCULATION OF REGISTRATION FEE
                                             
 
                  Proposed maximum       Proposed maximum            
        Amount to be       offering price per       aggregate offering       Amount of    
  Title of Securities to be Registered     registered (1)       share       price       registration fee    
 
Common Stock, $0.001 par value per share under the 2004 Stock Incentive Plan (the “Stock Plan”)
      800,000       $ 3.985 (2)     $ 3,188,000.00       $ 341.12    
 
Common Stock, $0.001 par value per share under the 2004 Employee Stock Purchase Plan (the “Purchase Plan”)
      246,000       $ 3.985 (2)     $ 980,310.00       $ 104.89    
 
Total:
      1,046,000       $ 3.985 (2)     $ 4,168,310.00       $ 446.01    
 
(1)   These represent the increase in the number of shares of common stock of the Registrant reserved for issuance under the Stock Plan and Purchase Plan by the Registrant pursuant to evergreen provisions therein. In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued resulting from stock splits, stock dividends, recapitalization or other similar transactions.
 
(2)   Represents the average of the high ($4.07) and low ($3.90) prices of the Common Stock July 31, 2006, and is set forth solely for the purposes of calculating the filing fee pursuant to Rule 457(h) and is used only for shares without a fixed exercise price. None of such shares have been issued or are subject to outstanding options.
 
 

 


 

EXPLANATORY NOTE
     Pursuant to General Instruction E of Form S-8, this registration statement incorporates by reference Registration Statement No. 333-113220 on Form S-8, filed with the Securities and Exchange Commission on March 2, 2004, which registered 3,500,000 shares of the Company’s common stock with respect to the 2004 Stock Incentive Plan for which a registration fee was paid with the filing of such Registration Statement, and 250,000 shares of the Company’s common stock with respect to the 2004 Employee Stock Purchase Plan, for which a registration fee was paid with the filing of such Registration Statement.
PART II
INFORMATION REQUIRED IN THE
REGISTRATION STATEMENT
Item 3.   Incorporation of Documents by Reference.
     The following documents filed by the Registrant with the Commission are incorporated by reference herein:
  1.   The Annual Report on Form 10-K of the Registrant for the fiscal year ended December 31, 2005, filed on March 16, 2006, as amended by Amendment No. 1 to 10-K, filed on August 4, 2006.
 
  2.   The Quarterly Reports on Form 10-Q of the Registrant for the three months ended March 31, 2006, filed on May 5, 2006, and for the three and six months ended June 30, 2006, filed on August 4, 2006.
 
  3.   The Registrant’s Current Reports on Form 8-K, filed on March 15, 2006, April 24, 2006, April 27, 2006, May 1, 2006 and July 28, 2006.
 
  4.   The description of the Registrant’s Common Stock contained in the Registrant’s Statement on Form 8-A, filed February 6, 2004, under the Exchange Act, including any amendment or report filed for the purpose of updating such description.
 
  5.   All documents filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act after the date of this Registration Statement, and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which de-registers all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such documents.
     Any statement contained in a document incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

2


 

Item 8.   Exhibits.
     
          5.1
  Opinion of Cooley Godward llp
 
   
          23.1
  Consent of Independent Registered Public Accounting Firm
 
   
          23.2
  Consent of Cooley Godward llp is contained in Exhibit 5.1 to this Registration Statement
 
   
          24.1
  Power of Attorney (see Signature Page)
 

3


 

SIGNATURES
     Pursuant to the requirements of the Securities Act, the Registrant, Dynavax Technologies Corporation, certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Berkeley, State of California, on August 4, 2006
         
  DYNAVAX TECHNOLOGIES CORPORATION
 
 
  By:   /s/ Dino Dina, M.D.    
    Dino Dina, M.D.   
    President, Chief Executive Officer and Director   
 
POWER OF ATTORNEY
     Each person whose signature appears below constitutes and appoints Dino Dina, M.D. and Deborah Smeltzer, and each of them, as attorneys-in-fact, each with the power of substitution, for him or her in any and all capacities, to sign any amendment to this Registration Statement and to file the same, with exhibits thereto and other documents in connection therewith, with the Commission, granting to said attorneys-in-fact, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming the said attorney-in-fact or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
     Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.
         
Signature   Title   Date
 
       
/s/ Dino Dina, M.D.
 
Dino Dina, M.D.
  President, Chief Executive Officer and Director (Principal Executive Officer)   August 4, 2006
 
       
/s/ Deborah A. Smeltzer
 
Deborah A. Smeltzer
  Vice President, Operations and Chief Financial Officer (Principal Financial Officer)   August 4, 2006
 
       
/s/ Timothy G. Henn
 
Timothy G. Henn
  Vice President, Finance and Administration (Principal Accounting Officer)   August 4, 2006
 
       
/s/ Arnold L. Oronsky, Ph.D.
 
Arnold L. Oronsky, Ph.D.
  Chairman of the Board    August 4, 2006
 
       
/s/ Nancy L. Buc
 
Nancy L. Buc
  Director    August 4, 2006
 
       
/s/ Dennis A. Carson, M.D.
 
Dennis A. Carson, M.D
  Director    August 4, 2006
 
       
/s/ Denise M. Gilbert
 
Denise M. Gilbert
  Director    August 4, 2006
 
       
/s/ Daniel S. Janney
 
Daniel S. Janney
  Director    August 4, 2006
 
       
/s/ Jan Leschly
 
Jan Leschly
  Director    August 4, 2006
 
       
/s/ Stanley A. Plotkin, M.D.
 
Stanley A. Plotkin, M.D.
  Director    August 4, 2006

4


 

INDEX TO EXHIBITS
     
Exhibit    
Number   Document
 
   
5.1
  Opinion of Cooley Godward llp
 
   
23.1
  Consent of Independent Registered Public Accounting Firm
 
   
23.2
  Consent of Cooley Godward llp is contained in Exhibit 5.1 to this Registration Statement
 
   
24.1
  Power of Attorney (see Signature Page)
 

 

exv5w1
 

Exhibit 5.1
[Letterhead of Cooley Godward LLP]
August 4, 2006
Dynavax Technologies Corporation
2929 Seventh Street, Suite 100
Berkeley, CA 94710
     Re:   2004 Stock Incentive Plan and 2004 Employee Stock Purchase Plan
Ladies and Gentlemen:
You have requested our opinion with respect to certain matters in connection with the filing by Dynavax Technologies Corporation (the “Company”) of a Registration Statement on Form S-8 (the “Registration Statement”) with the Securities and Exchange Commission covering the offering of up to an aggregate of 1,046,000 shares of the Company’s Common Stock, no par value, (the “Shares”) pursuant to its 2004 Stock Incentive Plan and 2004 Employee Stock Purchase Plan (collectively, the “Plans”).
In connection with this opinion, we have examined the Registration Statement and related Prospectus, your Certificate of Incorporation and By-laws, as amended, and such other documents, records, certificates, memoranda and other instruments as we deem necessary as a basis for this opinion. We have assumed the genuineness and authenticity of all documents submitted to us as originals, the conformity to originals of all documents submitted to us as copies thereof, and the due execution and delivery of all documents where due execution and delivery are a prerequisite to the effectiveness thereof.
On the basis of the foregoing, and in reliance thereon, we are of the opinion that the Shares, when sold and issued in accordance with the applicable Plan, the Registration Statement and related Prospectus, will be validly issued, fully paid, and nonassessable (except as to shares issued pursuant to certain deferred payment arrangements, which will be fully paid and nonassessable when such deferred payments are made in full).
We consent to the filing of this opinion as an exhibit to the Registration Statement.
Very truly yours,
Cooley Godward llp
By: /s/ Robert L. Jones                                             
       Robert L. Jones

 

exv23w1
 

Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
     We consent to the incorporation by reference in the following Registration Statements:
     (1) Registration Statement (Form S-3) and the related Prospectus of Dynavax Technologies Corporation for the registration of 2,000,000 shares of its common stock of Dynavax Technologies Corporation, and
     (2) Registration Statement (Form S-8) pertaining to the 2004 Stock Incentive Plan and 2004 Employee Stock Purchase Plan of Dynavax Technologies Corporation, of our reports dated March 10, 2006, with respect to the consolidated financial statements of Dynavax Technologies Corporation, Dynavax Technologies Corporation management’s assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of Dynavax Technologies Corporation, included in the Annual Report (Form 10-K/A) for the year ended December 31, 2005.
/s/ Ernst & Young LLP
San Francisco, California
August 1, 2006